Broadus A E, Insogna K L, Lang R, Ellison A F, Dreyer B E
N Engl J Med. 1984 Jul 12;311(2):73-80. doi: 10.1056/NEJM198407123110201.
In previous studies, we observed increases in the circulating concentration and production rate of 1,25-dihydroxyvitamin D (1,25-(OH)2D) in a large majority of patients with the syndrome of absorptive hypercalciuria. In the present study, the hypothesis that 1,25-(OD)2D production might be relatively autonomous in this syndrome was tested by fashioning a suppression test in which patients were challenged with a short-term increase in dietary calcium intake. We found that contrary to our hypothesis, the circulating concentration of 1,25-(OH)2D was remarkably sensitive to calcium intake in 15 patients with absorptive hypercalciuria (mean decrease, from 74 to 49 pg per milliliter, P less than 0.001). When this challenge was prolonged for two weeks, however, patients with absorptive hypercalciuria had evidence of an apparent "escape" phenomenon, in which the circulating concentration of 1,25-(OH)2D rebounded toward its initial level and the renal tubular phosphate threshold fell markedly. These findings provide evidence for disordered control of renal phosphate handling and 1,25-(OH)2D production in absorptive hypercalciuria and suggest a linked rather than a cause-and-effect relation between these two abnormalities.
在之前的研究中,我们观察到绝大多数吸收性高钙尿症患者的循环中1,25 - 二羟维生素D(1,25-(OH)₂D)浓度及生成率升高。在本研究中,通过设计一项抑制试验来检验1,25-(OH)₂D生成在该综合征中可能相对自主的假说,该试验中让患者短期增加膳食钙摄入量。我们发现,与我们的假说相反,15例吸收性高钙尿症患者的1,25-(OH)₂D循环浓度对钙摄入非常敏感(平均降低,从每毫升74皮克降至49皮克,P小于0.001)。然而,当这种刺激延长两周时,吸收性高钙尿症患者出现了明显的“逃逸”现象,即1,25-(OH)₂D循环浓度反弹至初始水平,且肾小管磷阈值显著下降。这些发现为吸收性高钙尿症中肾磷处理及1,25-(OH)₂D生成的调控紊乱提供了证据,并提示这两种异常之间存在关联而非因果关系。